Global Point of Care Diagnostic Testing World Markets 2015-2018 Featuring 100+ Companies/Organisations Across 25 Individual Market - Research and Markets

DUBLIN, August 22, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Point of Care Diagnostic Testing World Markets" report to their offering.

Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.

This report describes latest developments in the point of care testing market segment. It examines clinical instruments, devices and reagents and supplies as utilized in near-patient environments like hospital emergency rooms, critical care units, clinics and doctor's offices. The study defines the dollar volume of point of care sales and makes five year projections - both in the U.S. and worldwide - including Europe, Asia and Latin America.

It also examines in detail the point of care sector for 25 individual country markets. A detailed summary of all important instruments in each clinical market is provided with emphasis on newly introduced products. Moreover, parallel areas where rapid detection is important using hand-held devices such as rapid detection of food pathogens and infectious diseases (MRSA, herpes simplex, avian flu, West Nile virus and typhoid) are discussed. Growth moderators and developing trends in point of care applications, as well as technology platform innovations and connectivity questions are examined in detail.

The report surveys almost all of the companies known to be marketing, manufacturing or developing instruments and reagents for the point of care market in the U.S. and worldwide. Each company is discussed in depth, with a section on its history, product lines, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market data are also included.

Key Topics Covered:

1. Overview

2. Overview of Diagnostic Testing Point of Care Markets

2.1 Key Issues in the POC Diagnostic Testing Sector

2.2 Global Point of Care Marketplace

2.3 Shifts from Central Lab Testing to POCT

2.4 Geographical Distribution

2.5 Challenges of POCT

2.6 Key Issues for POCT

2.7 The Future of POCT

3. Summary Analysis of the Global POCT Market: Value, Growth Rates and Market Share

3.1 Global POCT Market

3.2 Global Market Revenues Analysis by Market Segment

3.3 Global Market Share Analysis

3.4 Global Market Size by Geographic Location

3.5 Global Market Size by Analyte Market Segment

3.6 Global POCT Testing by Location

4. Analysis of the U.S. POCT Market: Value, Growth Rates and Market Share

4.1 U.S. Market Revenues Analysis by Market Segment

4.2 U.S. Market Share Analysis

4.3 U.S. Market Size by Analyte Market Segment

5. Analysis of the European POCT Market: Value, Growth Rates and Market Shares

5.1 European Market Revenues Analysis

5.2 European Market Revenues Analysis by Geographic Region

5.3 European Market Revenues Analysis by Market Segment

5.4 European Market Share Analysis

6. Analysis of the POCT Markets for Japan, China and India: Value, Growth Rates and Market Share

6.1 Summary Analysis of Japanese, Chinese and Indian POCT Market Revenues

6.2 Summary of Asian (Japanese, Chinese and Indian) Market Revenues by Market Segment

6.3 Asian (Japanese, Chinese and Indian) Market Share Analysis

6.4 Summary Analysis of the Japanese POCT Market

6.5 Summary Analysis of the Indian POCT Market

6.6 Summary Analysis of the Chinese POCT Market

7. Analysis of the Rest of World (ROW) POCT Market: Value, Growth Rates and Market Share

7.1 Summary Analysis of the ROW POCT Market Revenues

7.2 Summary of the ROW Market Revenues by Market Segment

7.3 ROW Market Share Analysis

7.4 Summary Analysis of the ROW POCT Market Revenues

8. Review of the Market Segments, Reagents and Equipment

8.1 Blood Glucose Monitoring

8.2 Blood Gas and Electrolytes

8.3 Rapid Coagulation Tests

8.4 POC Rapid Cardiac Markers

8.5 POCT Substance Abuse Testing

8.6 POC Pregnancy and Fertility Tests

8.7 Fecal Occult Blood

8.8 POC Infectious Disease Testing

8.9 POC Urine Strip Testing

8.10 POC Cholesterol Testing

8.11 Miscellaneous POC Tests

8.12 HIV

9. POCT: Growth Regulators

9.1 Moderators of Growth

9.2 Personnel Acceptance

9.3 Key People for POCT

9.4 Information Management Issues

9.5 Key Elements for POCT

9.6 POCT and Reimbursement

9.7 Effectiveness of Clinical Outcomes

9.8 Rapid Near-Patient Testing in Hospitals

9.9 Satellite Facilities

9.10 Regionalization of Laboratory Care

9.11 Requirements for POCT

9.12 Locations of POC for Patient Care

9.13 Benefits of POCT

9.14 Cost Elements of POCT

9.15 Necessary Functions in POCT

9.16 Turnaround Time (TAT) for POCT

9.17 Clinical Laboratory Improvement Amendments (CLIA)

9.18 Sexually-Transmitted Diseases in Underdeveloped Countries

9.19 Sources of Error in POC Testing

10. Business Trends in the POC Sector

10.1 Sector Consolidation

10.2 Diagnostic Testing Growth Trends

10.3 Acquisition, License Agreements, Internal Development and Partnerships

10.4 Product Testing Depth in POCT

10.5 Government Regulation

10.6 Post-Filing Regulations for POC Devices

10.7 Exporting Unapproved POCTs

10.8 Analyte-Specific Reagents (Home-Brew Tests)

10.9 Medical Device Registration

10.10 Product Labeling

10.11 Punitive FDA Actions

10.12 CLIA 88 and State Laboratory Laws

10.13 Impact of Regulations on the Industry

10.14 Minimizing Regulatory Barriers

10.15 Waived Testing

11. Technology Platform Innovations in POCT

11.1 Latest POCT Technological Platforms

11.2 Smart Phone Technology

11.3 QuantuMDx Handheld, Portable Low Cost Rapid Devices

12. Data Management and Connectivity

12.1 Wireless LANs

12.2 Connectivity Platforms

12.3 Advantages of POCT Connectivity

13. Corporate Profiles

13.1 Abaxis, Inc.

13.2 Abbott Laboratories

13.3 AccuBioTech Co., Ltd.

13.4 Accriva Diagnostics

13.5 ACON Laboratories, Inc.

13.6 Acrongenomics

13.7 AgaMatrix

13.8 Aerscher Diagnostics, LLC

13.9 Akers Biosciences, Inc.

13.10 Alere

13.11 Alfa Scientific Designs, Inc.

13.12 American Bio Medica Corporation

13.13 Arkray, Inc.

13.14 Atlas Genetics Ltd.

13.15 Atonomics A/S

13.16 Audit Diagnostics

13.17 Augurix Diagnostics Ltd.

13.18 Axxin

13.19 Beckman Coulter (Danaher Corporation)

13.20 bioLytical Laboratories

13.21 Biomerica, Inc.

13.22 bioMérieux

13.23 BiOracle

13.24 Bio-Rad Laboratories, Inc.

13.25 BioScan Screening Systems, Inc.

13.26 Calypte Biomedical Corporation

13.27 Chembio Diagnostic, Inc.

13.28 Cholestech

13.29 Claros Diagnostics (OPKO Healthcare)

13.30 ERBA Diagnostics, Inc.

13.31 Daktari Diagnostics

13.32 Dexcom

13.33 Diagnostics for All

13.34 Enigma Diagnostics Ltd.

13.35 EY Laboratoires, Inc.

13.36 Eurotrol

13.37 Exalenz Bioscience

13.38 GenBio

13.39 Guided Therapeutics, Inc.

13.40 Helena Laboratories

13.41 Hema Diagnostic Systems, LLC

13.42 Instrumentation Laboratory (IL)/Werfen Group

13.43 Jant Pharmacal Corporation

13.44 Lein Applied Diagnostics

13.45 LifeSign, LLC

13.46 Medica Corporation

13.47 Medix Biochemica

13.48 MedMira Laboratories

13.49 A. Menarini Diagnostics

13.50 Micronics

13.51 New Horizons Diagnostics

13.52 Nova Biomedical

13.53 OraSure Technologies, Inc.

13.54 Orion Diagnostica

13.55 Polymedco, Inc.

13.56 Polymer Technology Systems, Inc.

13.57 Prima Biomedical Company

13.58 Qualigen

13.59 Quest Diagnostics, Inc.

13.60 Quidel Corporation

13.61 Radiometer Medical

13.62 Response Biomedical Corp.

13.63 Roche Diagnostics

13.64 Savyon Diagnostics

13.65 Seegene

13.66 Sekisui Diagnostics, LLC

13.67 Shanghai Ruicare Medical Co., Ltd.

13.68 Shenzhen Fitconn Technology Co., Ltd.

13.69 Shionogi & Co., Ltd.

13.70 Siemens AG

13.71 Siloam Biosciences, Inc.

13.72 Spectral Diagnostics, Inc.

13.73 StatSure Diagnostic Systems, Inc.

13.74 One Step Detect Associates, LLC

13.75 Senseonics

13.76 Telcare

13.77 Trinity Biotech Plc

13.78 Väsamed, Inc.

14. POCT Sector Trends and Forecasts

14.1 Home Care Analysis as Part of Near-Patient Testing

14.2 Non-Traditional Collection for POCT

14.3 New Systems for Critical Care and Near-Patient Testing

14.4 Utility of Near-Patient Testing in Critical-Care Settings

14.5 Physician's Office Market

14.6 Information Management Advances

14.7 Test-Ordering Patterns and Demand for POCT

14.8 Demand for Emergency Department Services

14.9 Move Away from the Central Laboratory

14.10 Healthcare Cost Controls

14.11 Mergers & Acquisitions

14.12 Competition for Services

14.13 Drivers of POCT

14.14 Confluence of New Technology

14.15 Difficulties of Design for POC Products

14.16 Point of Care Compliance

14.17 The Biggest New Opportunities in POCT

15. New Entrants to the Point of Care Market

15.1 Alliance International Co., Ltd.

15.2 Analyticon Biotechnologies AG

15.3 Ativa Medical Corporation

15.4 Aquila Diagnostic Systems, Inc.

15.5 ArcDia International Oyo Ltd.

15.6 Artron Laboratories, Inc.

15.7 Atlas Link Biotech Co., Ltd.

15.8 Audit Diagnostics

15.9 Autobio Diagnostics Co., Ltd.

15.10 Biocartis SA

15.11 BioFire Diagnostics, Inc.

15.12 BioMedomics

15.13 Biosensia Ltd.

15.14 Curetis AG

15.15 DxNA, LLC

15.16 Echo Therapeutics, Inc.

15.17 Gentag, Inc.

15.18 Great Basin Corporation

15.19 Immunexpress Group

15.20 Integrated Diagnostics

15.21 Integrity Applications

15.22 MBio Diagnostics, Inc.

15.23 Menssana Research, Inc.

15.24 Metaara Medical Technologies, Inc.

15.25 QuantuMDx Group

15.26 Venaxis, Inc.

15.27 Philips Business Group EBA

15.28 Wave 80 Biosciences

15.29 Veredus Laboratories Pte Ltd.

For more information about this report visit

http://www.researchandmarkets.com/research/g2cmk6/point_of_care

Related Topics: Point-of-Care Diagnostics

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets